Page last updated: 2024-08-23

phenyl acetate and Biliary Cirrhosis

phenyl acetate has been researched along with Biliary Cirrhosis in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (20.00)24.3611
2020's6 (60.00)2.80

Authors

AuthorsStudies
Aspinall, RJ; Berg, CP; Boudes, P; Bowlus, CL; Choi, YJ; Dörffel, Y; Galambos, MR; Goel, A; Gordon, SC; Harrison, SA; Hirschfield, GM; Jones, DEJ; Kremer, AE; Levy, C; Mayo, MJ; McWherter, CA; Neff, GW; Sheridan, DA; Shiffman, ML; Stanca, CM; Steinberg, A; Swain, MG; Thuluvath, PJ; Vierling, JM1
Mishra, AK; Singh, SP1
Bowlus, CL; Hirschfield, GM; Levy, C1
Dyson, JK; Jones, DEJ; Wetten, A1
Andreone, P; Aspinall, RJ; Boudes, PF; Bowlus, CL; Choi, YJ; Corpechot, C; Dalekos, GN; Drenth, JPH; Fassio, E; Forman, L; Gonzalez-Huezo, MS; Gordon, SC; Gulamhusein, A; Heneghan, MA; Hinrichsen, H; Hirschfield, GM; Invernizzi, P; Janczewska, E; Jeong, SH; Jones, DEJ; Kowdley, KV; Kremer, AE; Ladrón de Guevara, AL; Lawitz, EJ; Leggett, BA; Levy, C; Mayo, MJ; McWherter, CA; Nevens, F; Pratt, DS; Raikhelson, K; Ryder, SD; Shiffman, ML; Steinberg, A; Swain, MG; Trivedi, PJ; Vargas, V; Vierling, JM; Zigmond, E; Zuckerman, E1
Bowlus, CL; Choi, YJ; Hirschfield, G; Jones, DE; Kremer, AE; Levy, C; Mayo, MJ; McWherter, CA; Steinberg, A1
Hirschfield, GM; Webb, GJ1
Bak, LK; Dadsetan, S; Jalan, R; Keiding, S; Ott, P; Schousboe, A; Sørensen, M; Vilstrup, H; Waagepetersen, HS1
Grady, GF; Saravis, CA; Trey, C1
Losowsky, MS; Walls, WD1

Reviews

1 review(s) available for phenyl acetate and Biliary Cirrhosis

ArticleYear
Work in Progress: Drugs in Development.
    Clinics in liver disease, 2018, Volume: 22, Issue:3

    Topics: Abatacept; Acetates; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Bezafibrate; CD40 Antigens; CD40 Ligand; Chalcones; Chemokine CX3CL1; Chenodeoxycholic Acid; Cholic Acids; Drug Development; Fenofibrate; Fibroblast Growth Factors; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Janus Kinase Inhibitors; Liver Cirrhosis, Biliary; Methylamines; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR delta; PPAR gamma; Propionates; Pruritus; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Thiazepines; Triazoles; Ustekinumab

2018

Trials

2 trial(s) available for phenyl acetate and Biliary Cirrhosis

ArticleYear
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
    Journal of hepatology, 2022, Volume: 77, Issue:2

    Topics: Acetates; Adult; Alkaline Phosphatase; Disease Progression; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid

2022
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
    Hepatology (Baltimore, Md.), 2023, 08-01, Volume: 78, Issue:2

    Topics: Acetates; Alkaline Phosphatase; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Pruritus; Ursodeoxycholic Acid

2023

Other Studies

7 other study(ies) available for phenyl acetate and Biliary Cirrhosis

ArticleYear
Seladelpar in patients with primary biliary cholangitis: Need for a closer look!
    Journal of hepatology, 2022, Volume: 77, Issue:5

    Topics: Acetates; Cholagogues and Choleretics; Cholangitis; Humans; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid

2022
Reply to: "Seladelpar in patients with primary biliary cholangitis: Need for a closer look!"
    Journal of hepatology, 2022, Volume: 77, Issue:5

    Topics: Acetates; Cholangitis; Humans; Liver Cirrhosis, Biliary

2022
Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC).
    Expert opinion on investigational drugs, 2022, Volume: 31, Issue:10

    Topics: Acetates; Clinical Trials as Topic; Drugs, Investigational; Humans; Liver Cirrhosis, Biliary

2022
Seladelpar improved measures of pruritus, sleep, and fatigue and decreased serum bile acids in patients with primary biliary cholangitis.
    Liver international : official journal of the International Association for the Study of the Liver, 2022, Volume: 42, Issue:1

    Topics: Acetates; Bile Acids and Salts; Fatigue; Humans; Liver Cirrhosis, Biliary; Pruritus; Quality of Life; Sleep; Treatment Outcome

2022
Interorgan metabolism of ornithine phenylacetate (OP)--a novel strategy for treatment of hyperammonemia.
    Biochemical pharmacology, 2013, Jan-01, Volume: 85, Issue:1

    Topics: Acetates; Ammonia; Animals; Arteries; Bile Ducts; Drug Interactions; Female; Glutamine; Hyperammonemia; Kidney; Ligation; Liver; Liver Cirrhosis, Biliary; Muscle, Skeletal; Nitrogen Isotopes; Ornithine; Phenols; Rats; Rats, Wistar; Tissue Distribution

2013
Rapid screening test for detecting hepatitis-associated antigen.
    Science (New York, N.Y.), 1970, Jul-17, Volume: 169, Issue:3942

    Topics: Acetates; Cellulose; Cholelithiasis; Electrophoresis; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Immunodiffusion; Liver Cirrhosis, Biliary; Methods

1970
Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
    Thrombosis et diathesis haemorrhagica, 1969, Feb-28, Volume: 21, Issue:1

    Topics: Acetates; Adolescent; Adult; Age Factors; Aged; Blood Coagulation Factors; Calcium; Factor XIII; Female; Fibrinogen; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Thrombin; Time Factors

1969